Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Ex-Timing trial: evaluating morning, afternoon, and evening exercise on the circadian clock in individuals with type 2 diabetes and overweight/obesity-a randomized crossover study protocol.
Magalhães JP, Oliveira EC, Hetherington-Rauth M, Jesus F, Rodrigues MC, Raposo JF, Ribeiro RT, Caetano C, Sardinha LB. Magalhães JP, et al. Among authors: raposo jf. Trials. 2024 Aug 6;25(1):526. doi: 10.1186/s13063-024-08335-y. Trials. 2024. PMID: 39107793 Free PMC article.
EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescents.
Hoffmann L, Kohls M, Arnolds S, Achenbach P, Bergholdt R, Bonifacio E, Bosi E, Gündert M, Hoefelschweiger BK, Hummel S, Jarosz-Chobot P, Kordonouri O, Lampasona V, Narendran P, Overbergh L, Pociot F, Raposo JF, Šumník Z, Szypowska A, Vercauteren J, Winkler C, Mathieu C, Ziegler AG; EDENT1FI consortium. Hoffmann L, et al. Among authors: raposo jf. BMJ Open. 2025 Jan 2;15(1):e088522. doi: 10.1136/bmjopen-2024-088522. BMJ Open. 2025. PMID: 39753267 Free article.
Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study.
Patarrão RS, Meneses MJ, Ghadieh HE, Herrera L, Duarte S, Ribeiro RT, Raposo JF, Schmitt V, Singer BB, Gastaldelli A, Penha-Gonçalves C, Najjar SM, Macedo MP. Patarrão RS, et al. Among authors: raposo jf. Eur J Clin Invest. 2024 Dec;54 Suppl 2(Suppl 2):e14344. doi: 10.1111/eci.14344. Eur J Clin Invest. 2024. PMID: 39674875 Free PMC article.
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes.
Bertoluci MC, Silva Júnior WS, Valente F, Araujo LR, Lyra R, de Castro JJ, Raposo JF, Miranda PAC, Boguszewski CL, Hohl A, Duarte R, Salles JEN, Silva-Nunes J, Dores J, Melo M, de Sá JR, Neves JS, Moreira RO, Malachias MVB, Lamounier RN, Malerbi DA, Calliari LE, Cardoso LM, Carvalho MR, Ferreira HJ, Nortadas R, Trujilho FR, Leitão CB, Simões JAR, Dos Reis MIN, Melo P, Marcelino M, Carvalho D. Bertoluci MC, et al. Among authors: raposo jf. Diabetol Metab Syndr. 2023 Jul 19;15(1):160. doi: 10.1186/s13098-023-01121-x. Diabetol Metab Syndr. 2023. PMID: 37468901 Free PMC article. Review.
Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes.
Heller S, Raposo JF, Tofé S, Hanif W, Schroner Z, Down S, Blevins T. Heller S, et al. Among authors: raposo jf. Clin Diabetes. 2023 Spring;41(2):154-162. doi: 10.2337/cd22-0016. Epub 2022 Aug 9. Clin Diabetes. 2023. PMID: 37092154 Free PMC article.
85 results